RY 160.91 0.3555% SHOP 116.03 -0.4718% TD 83.98 0.2148% ENB 62.82 1.4699% BN 68.81 1.6396% TRI 251.78 0.6959% CNQ 39.88 2.0732% CP 103.16 1.9771% CNR 137.31 0.483% BMO 129.32 0.4661% BNS 65.69 0.551% CSU 4682.54 -0.7613% CM 81.6 0.1473% MFC 39.65 -0.0252% ATD 71.3 1.3072% NGT 76.22 -1.6643% TRP 68.46 0.9586% SU 47.8 2.006% WCN 273.36 0.3156% L 213.68 0.1594%

Matsumotokiyoshi Holdings Co. Ltd

Healthcare US MSMKF

16.515USD
-(-%)

Last update at 2025-04-17T13:30:00Z

Day Range

16.5216.52
LowHigh

52 Week Range

-112.7512.42
LowHigh

Fundamentals

  • Previous Close 16.52
  • Market Cap16858.46M
  • Volume0
  • P/E Ratio51.74
  • Dividend Yield1.46%
  • EBITDA92496.00M
  • Revenue TTM993937.98M
  • Revenue Per Share TTM2368.99
  • Gross Profit TTM 240295.00M
  • Diluted EPS TTM0.72

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Income before tax 64908.00M 49629.00M 32617.00M 39078.00M 37369.00M
Minority interest -220.00000M -24.00000M - - -
Net income 40545.00M 34588.00M 21568.00M 26176.00M 25035.00M
Selling general administrative 2131.00M 1686.00M 1397.00M 1788.00M 1388.00M
Selling and marketing expenses - - - - -
Gross profit 329320.00M 240295.00M 182096.00M 189438.00M 179482.00M
Reconciled depreciation 20840.00M 14861.00M 8578.00M 8403.00M 8233.00M
Ebit - 41408.00M 31522.00M 37554.00M 36029.00M
Ebitda 85801.00M 64550.00M 41239.00M 47499.00M 45619.00M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income 62280.00M 41411.00M 31538.00M 37567.00M 36032.00M
Other operating expenses - 11.00M 11.00M 11.00M 167.00M
Interest expense 53.00M 60.00M 44.00M 18.00M 17.00M
Tax provision 24141.00M 15016.00M 11049.00M 12902.00M 12333.00M
Interest income 130.00M 107.00M 88.00M 103.00M 116.00M
Net interest income 77.00M 47.00M 44.00M 85.00M 99.00M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - 15016.00M 11049.00M 12902.00M 12333.00M
Total revenue 951247.00M 729969.00M 556907.00M 590593.00M 575991.00M
Total operating expenses 888967.00M 688558.00M 525369.00M 553025.00M 539959.00M
Cost of revenue 621927.00M 489674.00M 374811.00M 401154.00M 396509.00M
Total other income expense net - - - - -
Discontinued operations - - - - -
Net income from continuing ops 40767.00M 34613.00M 21568.00M 26176.00M 25036.00M
Net income applicable to common shares - 34588.00M 21568.00M 26176.00M 25035.00M
Preferred stock and other adjustments - - - - -
Breakdown 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Total assets 688132.00M 656735.00M 368924.00M 351809.00M 318324.00M
Intangible assets 24829.00M 24319.00M 4862.00M 4533.00M 4147.00M
Earning assets - - - - -
Other current assets 10219.00M 11038.00M 4689.00M 6752.00M 8052.00M
Total liab 205417.00M 192395.00M 122464.00M 122506.00M 109057.00M
Total stockholder equity 482470.00M 464316.00M 246460.00M 229303.00M 209267.00M
Deferred long term liab - - - - -
Other current liab 24706.00M 41599.00M 23519.00M 22861.00M 22098.00M
Common stock - 22051.00M 22051.00M 22051.00M 22051.00M
Capital stock 22051.00M 22051.00M 22051.00M 22051.00M 22051.00M
Retained earnings 262001.00M 236264.00M 210627.00M 196253.00M 177270.00M
Other liab - 29666.00M 15857.00M 14128.00M 13323.00M
Good will 113125.00M 119046.00M 4029.00M 4870.00M 5756.00M
Other assets - 15248.00M 5351.00M 5371.00M 5362.00M
Cash 95224.00M 74519.00M 38517.00M 28368.00M 43353.00M
Cash and equivalents - - - - -
Total current liabilities 153270.00M 142449.00M 84887.00M 86202.00M 91828.00M
Current deferred revenue - - - - -
Net debt - - - - -
Short term debt - - - - -
Short long term debt 995.00M 884.00M - - -
Short long term debt total - - - - -
Other stockholder equity - 6503.00M 11459.00M 8710.00M 7718.00M
Property plant equipment - 107126.00M 72789.00M 74095.00M 73360.00M
Total current assets 329808.00M 304387.00M 175696.00M 160027.00M 168942.00M
Long term investments - - - - -
Net tangible assets - 320951.00M 237570.00M 219900.00M 199365.00M
Short term investments - - - - -
Net receivables 55470.00M 80870.00M 46047.00M 43003.00M 40714.00M
Long term debt 18400.00M 18400.00M 18400.00M 18400.00M -
Inventory 136480.00M 137960.00M 86443.00M 81904.00M 76823.00M
Accounts payable 102442.00M 92501.00M 55515.00M 57466.00M 64119.00M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 6717.00M 3191.00M 1534.00M 1710.00M 1727.00M
Deferred long term asset charges - - - - -
Non current assets total 358320.00M 352345.00M 193226.00M 191781.00M 149379.00M
Capital lease obligations 2017.00M 3636.00M 5300.00M 5780.00M 5793.00M
Long term debt total - - - - -
Breakdown 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Investments -19669.00000M 86.00M 459.00M -993.00000M 161.00M
Change to liabilities - -2255.00000M -1710.00000M -5848.00000M -1632.00000M
Total cashflows from investing activities - -15485.00000M -6311.00000M -48840.00000M -7872.00000M
Net borrowings - -993.00000M -993.00000M 18400.00M 18400.00M
Total cash from financing activities - -20337.00000M -9409.00000M 9089.00M -22290.00000M
Change to operating activities - -12940.00000M 5047.00M 1108.00M -803.00000M
Net income 40545.00M 34588.00M 21568.00M 26176.00M 25035.00M
Change in cash 20627.00M 36000.00M 10153.00M -14985.00000M -8264.00000M
Begin period cash flow 74519.00M 38517.00M 28363.00M 43349.00M 51613.00M
End period cash flow 95224.00M 74519.00M 38517.00M 28363.00M 43349.00M
Total cash from operating activities 64061.00M 39812.00M 25875.00M 24764.00M 21897.00M
Issuance of capital stock 157.00M - - - -
Depreciation 20840.00M 14861.00M 8578.00M 8403.00M 8233.00M
Other cashflows from investing activities - -3039.00000M -1229.00000M -2445.00000M -2485.00000M
Dividends paid -10580.00000M 8272.00M 7193.00M 7192.00M 6356.00M
Change to inventory -4601.00000M -466.00000M -4538.00000M -5080.00000M -6461.00000M
Change to account receivables - -807.00000M -3937.00000M -7.00000M -2567.00000M
Sale purchase of stock -11855.00000M -9009.00000M 0.00000M 0.00000M -13972.00000M
Other cashflows from financing activities - -2063.00000M -2216.00000M -2119.00000M -1962.00000M
Change to netincome - -8210.00000M -10182.00000M -12890.00000M -12242.00000M
Capital expenditures 16746.00M 9317.00M 3630.00M 4521.00M 4598.00M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -2394.00000M -6046.00000M -10638.00000M -12420.00000M -11287.00000M
Stock based compensation - - - - -
Other non cash items -714.00000M -10882.00000M 5544.00M 2611.00M -159.00000M
Free cash flow 47315.00M 28846.00M 20609.00M 18535.00M 16349.00M

Peer Comparison

Sector: Healthcare Industry: Pharmaceutical Retailers

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
MSMKF
Matsumotokiyoshi Holdings Co. Ltd
- -% 16.52 51.74 20.28 0.02 1.53 0.0066 0.07
WBA
Walgreens Boots Alliance Inc
0.09 0.83% 10.89 - 5.40 0.11 1.14 0.33 -4.3066
RADLY
Raia Drogasil SA ADR
- -% 3.56 47.15 32.68 0.34 9.83 0.35 3.29
ALBHF
Alibaba Health Information Technology Limited
- -% 0.55 50.80 29.59 0.30 3.62 1.58 34.83
ALBBY
Alibaba Health Information Technology Limited
- -% 11.15 48.10 30.30 0.29 3.70 1.58 34.83

Reports Covered

Stock Research & News

Profile

MatsukiyoCocokara & Co. operates and manages a chain of drug stores and health insurance prescription pharmacies in Japan. The company is involved in the franchising of its stores. MatsukiyoCocokara & Co. was founded in 1932 and is based in Tokyo, Japan.

Matsumotokiyoshi Holdings Co. Ltd

9-1 Shinmatsudo-Higashi, Matsudo, Japan, 270-8511

Key Executives

Name Title Year Born
Mr. Kiyoo Matsumoto Pres & Representative Director 1973
Mr. Takao Watanabe Exec. Officer & Deputy GM of Bus. Strategy Division NA
Mr. Takashi Matsumoto Sr. MD, GM of Sales Division & Director 1975
Mr. Akio Ishibashi Exec. Officer, GM of Corp. Planning Div., Head of Corp. Planning Department & Director 1964
Kazumasa Sugito Exec. Officer & Head of IT of Sales Division NA
Hiroshi Ando Exec. Officer NA
Ryoji Miyata Exec. Officer NA
Takashi Matsuda Exec. Officer NA
Hitoshi Takagi Exec. Officer NA
Mr. Takao Ota MD & Director 1951

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.